CDH1 and neoplasm: We assessed the expression of ECAD and FSP1 in untreated and treated primary tumours and small metastatic lesions, focusing only on single cells and nano-metastases since nearly all treated lesions fell into these two size categories (representative images in Supplementary Fig. 9a,c).